Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that. Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model i...
All content for The Science of Talent by BioTalent Canada is the property of BioTalent Canada and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that. Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model i...
Biotechnology – One Part Science, Two Parts Human Resources
The Science of Talent by BioTalent Canada
39 minutes
3 years ago
Biotechnology – One Part Science, Two Parts Human Resources
Bio Tech companies are committed to the business of science. It’s what we do every day. But there’s another commitment they’re engrossed in… attracting and retaining talented people. It’s an industry undergoing dramatic change with forecasts indicating the number of jobs will soon outnumber candidates by a ratio of four. So, what are Biotech leaders doing to prepare and respond to this? In episode one, host Rob Henderson, the CEO of BioTalent Canada talks with Reg Joseph, CEO of Heal...
The Science of Talent by BioTalent Canada
Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that. Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model i...